At the 2007 annual meeting of the Radiological Society of North America in November, the sparkle of new innovations was tarnished somewhat by questions about the rapid proliferation of advanced imaging technologies and their cost effectiveness. As a result both new and old technologies are facing an uphill battle to prove their worth in a heavily scrutinized economic environment.
by Scott Huntley
The annual meeting of the Radiological Society of North America (RSNA) is a showcase for the latest in advanced imaging...
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
The US FDA's new draft guidance details the responsibilities of new owners of 510(k) clearances, including making timely updates device listings in FURLS and GUDID to maintain accurate information for safety alerts and recalls. Comments on the draft are accepted until 4 August.
A US House bill would give the FDA $33.1m more in budget authority than requested by the Trump Administration for fiscal year 2026. The measure was sent to the full House Appropriations committee on a party-line vote.
During a recent FDLI panel, experts discussed the FDA's Home Healthcare initiative, highlighting its potential benefits and challenges. Key issues include usability testing, reimbursement, labeling for home use, and the need for innovation while ensuring patient safety.
The EU’s Artificial Intelligence Act, which entered into force on 1 August 2024, is already facing turbulence.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
The EU’s Artificial Intelligence Act, which entered into force on 1 August 2024, is already facing turbulence.
While HistoSonics is awaiting the CE mark in Europe, it hit a major milestone by securing early limited market access in Great Britain under a Unmet Clinical Need Authorization (UCNA), bringing its noninvasive histotripsy treatment to patients with liver tumors.
